Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease.

By M. Divo, C. Côté, J. D. de Torres, C. Casanova, J. Marin, V. Pinto-Plata, J. Zulueta, C. Cabrera, Jorge Zagaceta, G. Hunninghake and 1 more. American Journal of Respiratory and Critical Care Medicine, 2012

1,194 citations recorded by the source corpus.

Subfields: Epidemiology, Pulmonary and Respiratory Medicine, Sociology and Political Science

View Paper: https://www.semanticscholar.org/paper/1437f6adbedcfc60432df230128383d98997f93e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. David M. Mannino

In Pulmonary and Respiratory Medicine

1. R. Rodríguez-Roisín
2. Jorgen Vestbo
3. David M. Mannino
4. A. Anzueto
5. R. Stockley
6. D. Parums

In Sociology and Political Science

1. R. Rodríguez-Roisín
2. Jorgen Vestbo
3. A. Anzueto
4. R. Stockley

Citations in the corpus

• Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. (2017, background): “Hypertension is likely to be the most frequently occurring comorbidity in COPD and may have implications for prognosis.(308,324)”
• Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. (2013, background): “Indeed, anxiety was reported to be the strongest independent predictor of mortality in patients with COPD (5).”
• Ageing and the epidemiology of multimorbidity (2014, methodology): “Variability in comorbidity prevalence exists and probably represents the differences in disease ascertainment in each study, as they used administrative databases, patient self-reported disease, and data extracted from medical records or measured with specific cut-offs [42, 44, 46, 48, 49].”
• Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary (2023, neutral): “Patients with COPD frequently harbor other comorbid diseases (multimorbidity) that influence their clinical condition and prognosis (73), independently of the severity of airflow obstruction due to COPD (73), and require specific treatment (see below).”